Harmony Biosciences Holdings Inc (HRMY)
29.81
+0.88
(+3.04%)
USD |
NASDAQ |
Apr 26, 10:29
Harmony Biosciences Holdings 1 Year Total Returns (Daily): -8.91% for April 25, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 25, 2024 | -8.91% |
April 24, 2024 | -9.81% |
April 23, 2024 | -10.96% |
April 22, 2024 | -9.41% |
April 19, 2024 | -10.83% |
April 18, 2024 | -12.82% |
April 17, 2024 | -12.47% |
April 16, 2024 | -5.49% |
April 15, 2024 | -6.32% |
April 12, 2024 | -4.25% |
April 11, 2024 | -1.31% |
April 10, 2024 | -7.17% |
April 09, 2024 | 1.18% |
April 08, 2024 | -2.16% |
April 05, 2024 | -1.19% |
April 04, 2024 | 0.32% |
April 03, 2024 | -4.49% |
April 02, 2024 | 0.15% |
April 01, 2024 | 1.10% |
March 28, 2024 | 9.03% |
March 27, 2024 | -19.23% |
March 26, 2024 | -23.20% |
March 25, 2024 | -21.80% |
March 22, 2024 | -21.12% |
March 21, 2024 | -23.75% |
Date | Value |
---|---|
March 20, 2024 | -23.46% |
March 19, 2024 | -22.88% |
March 18, 2024 | -24.64% |
March 15, 2024 | -21.31% |
March 14, 2024 | -24.43% |
March 13, 2024 | -27.91% |
March 12, 2024 | -26.27% |
March 11, 2024 | -25.40% |
March 08, 2024 | -28.30% |
March 07, 2024 | -28.18% |
March 06, 2024 | -29.16% |
March 05, 2024 | -28.89% |
March 04, 2024 | -28.61% |
March 01, 2024 | -24.99% |
February 29, 2024 | -27.10% |
February 28, 2024 | -24.46% |
February 27, 2024 | -25.20% |
February 26, 2024 | -28.37% |
February 23, 2024 | -29.50% |
February 22, 2024 | -32.03% |
February 21, 2024 | -24.67% |
February 20, 2024 | -32.98% |
February 16, 2024 | -30.56% |
February 15, 2024 | -28.19% |
February 14, 2024 | -27.95% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-62.86%
Minimum
Oct 27 2023
108.0%
Maximum
Aug 02 2022
4.45%
Average
-1.46%
Median
Nov 04 2021
1 Year Total Returns (Daily) Benchmarks
Amylyx Pharmaceuticals Inc | -93.98% |
Exelixis Inc | 24.83% |
Insmed Inc | 32.27% |
Arcturus Therapeutics Holdings Inc | -6.80% |
Ultragenyx Pharmaceutical Inc | 4.78% |